Intranasal fluticasone propionate. A reappraisal of its pharmacology and clinical efficacy in the treatment of rhinitis

Drugs

Volumn 53, Issue 5, 1997, Pages 885-907

  Wiseman, L R ^a   Benfield, P ^a  

^a ADIS INTERNATIONAL LIMITED   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; ASTEMIZOLE; BECLOMETASONE; BUDESONIDE; CETIRIZINE; CROMOGLYCATE DISODIUM; FLUNISOLIDE; FLUTICASONE PROPIONATE; GLUCOCORTICOID RECEPTOR; LORATADINE; TERFENADINE; TRIAMCINOLONE ACETONIDE;

ALLERGIC RHINITIS; ANTIINFLAMMATORY ACTIVITY; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG POTENCY; EPISTAXIS; HEADACHE; HEART DISEASE; HUMAN; INTRANASAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NOSE IRRITATION; NOSE POLYP; ORAL DRUG ADMINISTRATION; PERENNIAL RHINITIS; QUALITY OF LIFE; RECEPTOR AFFINITY; REVIEW; SKIN MANIFESTATION; SORE THROAT;

EID: 0030938963     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199753050-00014     Document Type: Review

References (114)

1. 1. HM Bryson D Faulds 1992 Intranasal fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in allergic rhinitis Drugs 43 760 75 1379151 1:STN:280:DyaK38zkslajtA%3D%3D 10.2165/00003495-199243050-00009 Bryson HM, Faulds D. Intranasal fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in allergic rhinitis. Drugs 1992 May; 43: 760–75
2. 2. P Högger P Rohdewald 1994 Binding kinetics of fluticasone propionate to the human glucocorticoid receptor Steroids 59 597 602 7878687 10.1016/0039-128X(94)90054-X Högger P, Rohdewald P. Binding kinetics of fluticasone propionate to the human glucocorticoid receptor. Steroids 1994; 59: 597–602
3. 3. M Johnson 1995 The anti-inflammatory profile of fluticasone propionate Allergy 50 23 11 4 7604948 1:CAS:528:DyaK2MXlslCntbo%3D 10.1111/j.1398-9995.1995.tb02735.x Johnson M. The anti-inflammatory profile of fluticasone propionate. Allergy 1995; 50 Suppl. 23: 11–4
4. 4. N Mygind 1993 Glucocorticosteroids and rhinitis Allergy 48 476 90 8238807 1:CAS:528:DyaK2cXhsFersbs%3D 10.1111/j.1398-9995.1993.tb01103.x Mygind N. Glucocorticosteroids and rhinitis. Allergy 1993 Oct; 48: 476–90
5. 5. AM Bentley NR Jacobson V Cumbeworth 1992 Immunohistology of the nasal mucosa in seasonal allergic rhinitis: increases in activated eosinophils and epithelial mast cells J Allergy Clin Immunol 89 877 83 1532808 1:STN:280:DyaK383hvVOmug%3D%3D 10.1016/0091-6749(92)90444-7 Bentley AM, Jacobson NR, Cumbeworth V, et al. Immunohistology of the nasal mucosa in seasonal allergic rhinitis: increases in activated eosinophils and epithelial mast cells. J Allergy Clin Immunol 1992; 89: 877–83
6. 6. M Viegas E Gomez J Brooks 1987 Effect of the pollen season on nasal mast cells BMJ 296 1572 3 Viegas M, Gomez E, Brooks J, et al. Effect of the pollen season on nasal mast cells. BMJ 1987; 296: 1572–3
7. 7. E Gomez JE Clague D Gatland 1988 Effect of topical corticosteroids on seasonally induced increases in nasal mast cells BMJ 296 1572 3 3135013 1:STN:280:DyaL1c3otF2ntw%3D%3D 10.1136/bmj.296.6636.1572-a Gomez E, Clague JE, Gatland D, et al. Effect of topical corticosteroids on seasonally induced increases in nasal mast cells. BMJ 1988; 296: 1572–3
8. 8. I Feather S Wilson S Smith 1992 The accumulation of mast cells and eosinophils in the nasal mucosa in seasonal allergic rhinitics during natural pollen exposure, is inhibited by prophylactic fluticasone propionate aqueous nasal spray [abstract] Am Rev Respir Dis 145 A853 Feather I, Wilson S, Smith S, et al. The accumulation of mast cells and eosinophils in the nasal mucosa in seasonal allergic rhinitics during natural pollen exposure, is inhibited by prophylactic fluticasone propionate aqueous nasal spray [abstract]. Am Rev Respir Dis 1992 Apr; 145: A853
9. 9. I Feather S Wilson S Smith 1992 Prophylactic fluticasone propionate aqueous nasal spray inhibits the accumulation of mucosal eosinophils and mast cells in seasonal allergic rhinitis [abstract] Allergy 47 12 249 Feather I, Wilson S, Smith S, et al. Prophylactic fluticasone propionate aqueous nasal spray inhibits the accumulation of mucosal eosinophils and mast cells in seasonal allergic rhinitis [abstract]. Allergy 1992; 47(12) Suppl.: 249
10. 10. S Juliusson K Holmberg G Karlsson 1993 Mast cells and mediators in the nasal mucosa after allergen challenge. Effects of four weeks’ treatment with topical glucocorticoid Clin Exp Allergy 23 591 9 7693314 1:STN:280:DyaK2c%2Fjs1egsw%3D%3D 10.1111/j.1365-2222.1993.tb00899.x Juliusson S, Holmberg K, Karlsson G, et al. Mast cells and mediators in the nasal mucosa after allergen challenge. Effects of four weeks’ treatment with topical glucocorticoid. Clin Exp Allergy 1993 Jul; 23: 591–9
11. 11. Holmberg K, Juliusson S, Karlsson G, et al. Effects of 4 weeks treatment with the topical glucocorticoid fluticasone on allergen-induced symptoms, tissue mast cells and histamine in the nasal mucosa [abstract]. XIV International Congress of Allergology and Clinical Immunology; 1991 Oct 13–18; Kyoto, 183
12. 12. S Rak MR Jacobson RM Sudderick 1994 Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challenge Clin Exp Allergy 24 930 9 7842362 1:STN:280:DyaK2M7ksVKitQ%3D%3D 10.1111/j.1365-2222.1994.tb02724.x Rak S, Jacobson MR, Sudderick RM, et al. Influence of prolonged treatment with topical corticosteroid (fluticasone propionate) on early and late phase nasal responses and cellular infiltration in the nasal mucosa after allergen challenge. Clin Exp Allergy 1994 Oct; 24: 930–9
13. 13. MR Jacobson S Rak RM Sudderick 1994 Influence of prolonged treatment with topical corticosteroid on allergen-induced cellular infiltration in the nasal mucosa [abstract] Clin Exp Allergy 24 183 Jacobson MR, Rak S, Sudderick RM, et al. Influence of prolonged treatment with topical corticosteroid on allergen-induced cellular infiltration in the nasal mucosa [abstract]. Clin Exp Allergy 1994 Feb; 24: 183
14. 14. AF Holm WJ Fokkens T Godthelp 1995 Effect of 3 months’ nasal steroid therapy on nasal T cells and Langerhans cells in patients suffering from allergic rhinitis Allergy 50 204 9 7677236 1:STN:280:DyaK2MvgslOgsg%3D%3D 10.1111/j.1398-9995.1995.tb01134.x Holm AF, Fokkens WJ, Godthelp T, et al. Effect of 3 months’ nasal steroid therapy on nasal T cells and Langerhans cells in patients suffering from allergic rhinitis. Allergy 1995 Mar; 50: 204–9
15. 15. T Godthelp AF Holm H Blom 1995 The effect of fluticasone propionate aqueous nasal spray on nasal mucosal inflammation in perennial allergic rhinitis Allergy 50 23 21 4 7604950 1:CAS:528:DyaK2MXlslCntbs%3D 10.1111/j.1398-9995.1995.tb02737.x Godthelp T, Holm AF, Blom H, et al. The effect of fluticasone propionate aqueous nasal spray on nasal mucosal inflammation in perennial allergic rhinitis. Allergy 1995; 50 Suppl. 23: 21–4
16. 16. MM Weinberger 1995 Placebo-controlled versus comparative studies of drug effects [letter] J Pediatr 126 680 1 7699560 1:STN:280:DyaK2M3htl2hsg%3D%3D 10.1016/S0022-3476(95)70388-8 Weinberger MM. Placebo-controlled versus comparative studies of drug effects [letter]. J Pediatr 1995 Apr; 126: 680–1
17. 17. IM Garrelds C Graaf-in’t Veld De APH Jansen 1994 Effect of fluticasone propionate aqueous nasal spray treatment on platelet activating factor and eicosanoid production by nasal mucosa in patients with a house dust mite allergy Mediators Inflamm 3 381 5 18475584 1:STN:280:DC%2BD1czht1ersA%3D%3D 10.1155/S0962935194000530 Garrelds IM, De Graaf-in’t Veld C, Jansen APH, et al. Effect of fluticasone propionate aqueous nasal spray treatment on platelet activating factor and eicosanoid production by nasal mucosa in patients with a house dust mite allergy. Mediators Inflamm 1994 Oct; 3: 381–5
18. 18. GK Scadding YC Darby CE Austin 1994 Effect of short-term treatment with fluticasone propionate nasal spray on the response to nasal allergen challenge Br J Clin Pharmacol 38 447 51 7893587 1:STN:280:DyaK2M3gtVOrsA%3D%3D 10.1111/j.1365-2125.1994.tb04381.x Scadding GK, Darby YC, Austin CE. Effect of short-term treatment with fluticasone propionate nasal spray on the response to nasal allergen challenge. Br J Clin Pharmacol 1994 Nov; 38: 447–51
19. 19. IM Garrelds C Graaf-in’t Veld De M-N Nahori 1995 Interleukin-5 and eosinophil catationic protein in nasal lavages of rhinitis patients Eur J Pharmacol 275 295 300 7768298 1:CAS:528:DyaK2MXks1KgtLY%3D 10.1016/0014-2999(95)00049-Q Garrelds IM, De Graaf-in’t Veld C, Nahori M-N, et al. Interleukin-5 and eosinophil catationic protein in nasal lavages of rhinitis patients. Eur J Pharmacol 1995 Mar 14; 275: 295–300
20. 20. T Godthelp AF Holm HM Blom 1996 A double-blind comparison of two different dosages of fluticasone propionate aqueous nasal spray in the treatment of patients with allergic perennial rhinitis-a biopsy study Allergologie 19 42 Godthelp T, Holm AF, Blom HM, et al. A double-blind comparison of two different dosages of fluticasone propionate aqueous nasal spray in the treatment of patients with allergic perennial rhinitis-a biopsy study. Allergologie 1996; 19: 42
21. 21. K Masuyama MR Jacobson S Rak 1994 Topical glucocortico-steroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis Immunology 82 192 9 7927488 1:CAS:528:DyaK2cXksFSgt7s%3D Masuyama K, Jacobson MR, Rak S, et al. Topical glucocortico-steroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis. Immunology 1994 Jun; 82: 192–9
22. 22. K Masuyama S Rak MR Jacobson 1994 Rhinitis at the cellular level Eur Resp Rev 4 252 5 Masuyama K, Rak S, Jacobson MR, et al. Rhinitis at the cellular level. Eur Resp Rev 1994; 4: 252–5
23. 23. CH Banov TR Woehler CF LaForce 1994 Once daily intranasal fluticasone propionate is effective for perennial allergic rhinitis Ann Allergy 73 240 6 8092559 1:STN:280:DyaK2cznvFCqtQ%3D%3D Banov CH, Woehler TR, LaForce CF, et al. Once daily intranasal fluticasone propionate is effective for perennial allergic rhinitis. Ann Allergy 1994 Sep; 73: 240–6
24. 24. MA Birchall JC Henderson JM Studham 1995 The effect of topical fluticasone propionate on intranasal histamine challenge in subjects with perennial allergic rhinitis Clin Otolaryngol 20 204 10 7554327 1:STN:280:DyaK28%2FkslGlsw%3D%3D 10.1111/j.1365-2273.1995.tb01848.x Birchall MA, Henderson JC, Studham JM, et al. The effect of topical fluticasone propionate on intranasal histamine challenge in subjects with perennial allergic rhinitis. Clin Otolaryngol 1995 Jun; 20: 204–10
25. 25. RJ Dockhorn BR Pauli EO Meltzer 1993 Once-versus twice-daily fluticasone propionate aqueous nasal spray for seasonal allergic rhinitis Am J Rhinol 7 77 83 10.2500/105065893781976519 Dockhorn RJ, Pauli BR, Meltzer EO, et al. Once-versus twice-daily fluticasone propionate aqueous nasal spray for seasonal allergic rhinitis. Am J Rhinol 1993 Mar–Apr; 7: 77–83
26. 26. A Foresi A Pelucchi G Gherson 1996 Once daily intranasal fluticasone propionate (200µg) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis J Allergy Clin Immunol 98 274 82 8757203 1:CAS:528:DyaK28XlvVOqs7Y%3D 10.1016/S0091-6749(96)70150-1 Foresi A, Pelucchi A, Gherson G, et al. Once daily intranasal fluticasone propionate (200µg) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitis. J Allergy Clin Immunol 1996; 98: 274–82
27. 27. S Lozewicz J Wang J Duddle 1992 Topical glucocorticoids inhibit activation by allergen in the upper respiratory tract J Allergy Clin Immunol 89 951 7 1583252 1:STN:280:DyaK383lvFOrtQ%3D%3D 10.1016/0091-6749(92)90217-P Lozewicz S, Wang J, Duddle J, et al. Topical glucocorticoids inhibit activation by allergen in the upper respiratory tract. J Allergy Clin Immunol 1992 May; 89: 951–7
28. 28. EO Meltzer 1995 Nasal cytological changes following pharmacological intervention Allergy 50 23 15 20 7604949 1:STN:280:DyaK2MzivVKrug%3D%3D 10.1111/j.1398-9995.1995.tb02736.x Meltzer EO. Nasal cytological changes following pharmacological intervention. Allergy 1995; 50 Suppl. 23: 15–20
29. 29. EO Meltzer HA Orgel PR Rogenes 1994 Nasal cytology in patients with allergic rhinitis: effects of intranasal fluticasone propionate J Allergy Clin Immunol 94 708 15 7930304 1:CAS:528:DyaK2MXpsFaiuro%3D 10.1016/0091-6749(94)90178-3 Meltzer EO, Orgel HA, Rogenes PR. Nasal cytology in patients with allergic rhinitis: effects of intranasal fluticasone propionate. J Allergy Clin Immunol 1994 Oct; 94: 708–15
30. 30. RA Nathan EA Bronsky P Fireman 1991 Once daily fluticasone propionate aqueous nasal spray is an effective treatment for seasonal allergic rhinitis Ann Allergy 67 332 8 1897811 1:STN:280:DyaK3MznvVSqtg%3D%3D Nathan RA, Bronsky EA, Fireman P, et al. Once daily fluticasone propionate aqueous nasal spray is an effective treatment for seasonal allergic rhinitis. Ann Allergy 1991 Sep; 67: 332–8
31. 31. A van-As EA Bronsky RJ Dockhorn 1993 Once daily fluticasone propionate is as effective for perennial allergic rhinitis as twice daily beclomethasone diproprionate J Allergy Clin Immunol 91 1146 54 8509578 1:STN:280:DyaK3s3os1egtw%3D%3D 10.1016/0091-6749(93)90317-9 van-As A, Bronsky EA, Dockhorn RJ, et al. Once daily fluticasone propionate is as effective for perennial allergic rhinitis as twice daily beclomethasone diproprionate. J Allergy Clin Immunol 1993 Jun; 91: 1146–54
32. 32. J van-Bavel SR Findlay FC Hampel Jr 1994 Intranasal fluticasone propionate is more effective than terfenadine tablets for seasonal allergic rhinitis [published erratum appears in Arch Intern Med 1995 Feb 13;155 (3):276] Arch Intern Med 154 2699 704 7993153 1:STN:280:DyaK2M%2FosFeltw%3D%3D 10.1001/archinte.1994.00420230086010 van-Bavel J, Findlay SR, Hampel Jr FC, et al. Intranasal fluticasone propionate is more effective than terfenadine tablets for seasonal allergic rhinitis [published erratum appears in Arch Intern Med 1995 Feb 13;155 (3):276]. Arch Intern Med 1994 Dec 12–26; 154: 2699–704
33. 33. C Graaf-in’t Veld De IM Garrelds APH Jansen 1995 Effect of intranasal fluticasone propionate on the immediate and late allergic reaction and nasal hyperreactivity in patients with a house dust mite allergy Clin Exp Allergy 25 966 73 8556568 10.1111/j.1365-2222.1995.tb00399.x De Graaf-in’t Veld C, Garrelds IM, Jansen APH, et al. Effect of intranasal fluticasone propionate on the immediate and late allergic reaction and nasal hyperreactivity in patients with a house dust mite allergy. Clin Exp Allergy 1995; 25: 966–73
34. 34. A Konno T Yamakoshi N Terada 1994 Mode of action of a topical steroid on immediate phase reaction after antigen challenge and nonspecific nasal hyperreactivity in nasal allergy Int Arch Allergy Immunol 103 1 79 87 8260854 1:STN:280:DyaK2c%2FotlynsA%3D%3D 10.1159/000236609 Konno A, Yamakoshi T, Terada N, et al. Mode of action of a topical steroid on immediate phase reaction after antigen challenge and nonspecific nasal hyperreactivity in nasal allergy. Int Arch Allergy Immunol 1994; 103(1): 79–87
35. 35. GH Phillips 1990 Structure-activity relationships of topically active steroids: the selection of fluticasone propionate Respir Med 84 A 19 23 10.1016/S0954-6111(08)80003-0 Phillips GH. Structure-activity relationships of topically active steroids: the selection of fluticasone propionate. Respir Med 1990; 84 Suppl. A: 19–23
36. 36. Andersson N, Klint S, Randwall G, et al. Equipotency of budesonide and fluticasone propionate in the vasoconstriction assay [abstract]. Thorax 1994; 149: 422P
37. 37. English AF, Neate MS, Quint DJ, et al. Some biological activities of a new corticosteroid, fluticasone propionate [abstract]. Br J Pharmacol 1994 Jul; 112 Suppl: 591P
38. 38. Ransom J, Rogenes P, Field E, et al. Fluticasone propionate aqueous nasal spray increases mean total nasal airflow compared with astemizole or terfenadine [abstract]. In: 1994 Annual Meeting — American College of Allergy and Immunology; 1994: 55
39. 39. EA Bronsky RJ Dockhorn EO Meltzer 1996 Fluticasone propionate aqueous nasal spray compared with terfenadine tablets in the treatment of seasonal allergic rhinitis J Allergy Clin Immunol 97 915 21 8655886 1:CAS:528:DyaK28XivVKjtb0%3D 10.1016/S0091-6749(96)80065-0 Bronsky EA, Dockhorn RJ, Meltzer EO, et al. Fluticasone propionate aqueous nasal spray compared with terfenadine tablets in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol 1996 Apr; 97: 915–21
40. 40. G Jordana J Dolovich MP Briscoe 1996 Intranasal fluticasone propionate versus loratadine in the treatment of adolescent patients with seasonal allergic rhinitis J Allergy Clin Immunol 97 588 95 8621843 1:CAS:528:DyaK28XhslOltbo%3D 10.1016/S0091-6749(96)70303-2 Jordana G, Dolovich J, Briscoe MP, et al. Intranasal fluticasone propionate versus loratadine in the treatment of adolescent patients with seasonal allergic rhinitis. J Allergy Clin Immunol 1996 Feb; 97: 588–95
41. 41. BM Prenner 1996 Hypothalamic-pituitary-adrenal axis suppression during inhaled or intranasal corticosteroid treatment Adv Ther 13 154 60 Prenner BM. Hypothalamic-pituitary-adrenal axis suppression during inhaled or intranasal corticosteroid treatment. Adv Ther 1996; 13: 154–60
42. 42. U Knutsson P Stierna C Marcus 1995 Effects of intranasal glucocorticoids on endogenous glucocorticoid peripheral and central function J Endocrinol 144 301 10 7706983 1:CAS:528:DyaK2MXktVGks7s%3D 10.1677/joe.0.1440301 Knutsson U, Stierna P, Marcus C, et al. Effects of intranasal glucocorticoids on endogenous glucocorticoid peripheral and central function. J Endocrinol 1995 Feb; 144: 301–10
43. 43. AE Mackie GP Ventresca RW Fuller 1996 Pharmacokinetics of intravenous fluticasone propionate in healthy subjects Br J Clin Pharmacol 41 539 42 8799519 1:CAS:528:DyaK28XktlGrt7k%3D 10.1046/j.1365-2125.1996.36110.x Mackie AE, Ventresca GP, Fuller RW, et al. Pharmacokinetics of intravenous fluticasone propionate in healthy subjects. Br J Clin Pharmacol 1996 Jun; 41: 539–42
44. 44. GP Ventresca AE Mackie JA Moss 1994 Absorption of oral fluticasone propionate in healthy subjects [abstract] Am J Respir Crit Care Med 149 214 Ventresca GP, Mackie AE, Moss JA, et al. Absorption of oral fluticasone propionate in healthy subjects [abstract]. Am J Respir Crit Care Med 1994 Apr; 149 (Pt2): 214
45. 45. C Falcoz AE Mackie J McDowall 1996 Oral bioavailability of fluticasone propionate in healthy subjects [abstract] Br J Clin Pharmacol 41 459P 60P Falcoz C, Mackie AE, McDowall J, et al. Oral bioavailability of fluticasone propionate in healthy subjects [abstract]. Br J Clin Pharmacol 1996 May; 41: 459P–60P
46. 46. R Fuller M Johnson A Bye 1995 Fluticasone propionate — an update on preclinical and clinical experience Respir Med 89 A 3 18 7569173 10.1016/0954-6111(95)90259-7 Fuller R, Johnson M, Bye A. Fluticasone propionate — an update on preclinical and clinical experience. Respir Med 1995; 89 Suppl.A: 3–18
47. 47. SM Harding 1990 The human pharmacology of fluticasone propionate Respir Med 84 A 25 9 2287792 10.1016/S0954-6111(08)80004-2 Harding SM. The human pharmacology of fluticasone propionate. Respir Med 1990; 84 Suppl.A: 25–9
48. 48. JE McDowall AE Mackie A Bye 1995 Very low systemic exposure to intranasal fluticasone propionate [abstract] J Allergy Clin Immunol 95 194 McDowall JE, Mackie AE, Bye A, et al. Very low systemic exposure to intranasal fluticasone propionate [abstract]. J Allergy Clin Immunol 1995; 95 (Pt 2): 194
49. 49. S Edsbacker K-E Andersson Ryrfeldt 1985 Nasal bioavailability and systemic effects of the glucocorticoid budesonide in man Eur J Clin Pharmacol 29 477 81 3912192 1:STN:280:DyaL287js1ajtQ%3D%3D 10.1007/BF00613465 Edsbacker S, Andersson K-E, Ryrfeldt Å. Nasal bioavailability and systemic effects of the glucocorticoid budesonide in man. Eur J Clin Pharmacol 1985; 29: 477–81
50. 50. A Kwaselow J McLean W Busse 1985 A comparison of intranasal and oral flunisolide in the therapy of allergic rhinitis. Evidence for a topical effect Allergy 40 363 7 3898905 1:STN:280:DyaL2MzgsVOgsg%3D%3D 10.1111/j.1398-9995.1985.tb00248.x Kwaselow A, McLean J, Busse W, et al. A comparison of intranasal and oral flunisolide in the therapy of allergic rhinitis. Evidence for a topical effect. Allergy 1985; 40: 363–7
51. 51. F Hampel W Howland B Martin 1994 The efficacy of fluticasone propionate aqueous nasal spray for treatment of rhinitis is dependent on topical application [abstract] J Allergy Clin Immunol 93 165 Hampel F, Howland W, Martin B, et al. The efficacy of fluticasone propionate aqueous nasal spray for treatment of rhinitis is dependent on topical application [abstract]. J Allergy Clin Immunol 1994 Jan; 93: 165,Pt2
52. 52. J Dolovich AG Wong WB Chodirker 1994 Multicenter trial of fluticasone propionate aqueous nasal spray in ragweed allergic rhinitis Ann Allergy 73 147 53 8067598 1:STN:280:DyaK2czks1KmsA%3D%3D Dolovich J, Wong AG, Chodirker WB, et al. Multicenter trial of fluticasone propionate aqueous nasal spray in ragweed allergic rhinitis. Ann Allergy 1994 Aug; 73: 147–53
53. 53. CF Laforce RJ Dockhorn SR Findlay 1994 Fluticasone propionate: an effective alternative treatment for seasonal allergic rhinitis in adults and adolescents J Fam Pract 38 145 52 8308505 1:STN:280:DyaK2c7ktFCmtg%3D%3D Laforce CF, Dockhorn RJ, Findlay SR, et al. Fluticasone propionate: an effective alternative treatment for seasonal allergic rhinitis in adults and adolescents. J Fam Pract 1994 Feb; 38: 145–52
54. 54. J Dolovich M O’Connor N Stepner 1994 Double-blind comparison of intranasal fluticasone propionate, 200µg once daily with 200µg twice daily in the treatment of patients with severe seasonal allergic rhinitis to ragweed Ann Allergy 72 435 40 8179230 1:STN:280:DyaK2c3jsVKjuw%3D%3D Dolovich J, O’Connor M, Stepner N. Double-blind comparison of intranasal fluticasone propionate, 200µg once daily with 200µg twice daily in the treatment of patients with severe seasonal allergic rhinitis to ragweed. Ann Allergy 1994 May; 72: 435–40
55. 55. B Pedersen R Dahl DH Richards 1995 Once daily fluticasone propionate aqueous nasal spray controls symptoms of most patients with seasonal allergic rhinitis Allergy 50 794 9 8607560 1:CAS:528:DyaK28Xltlamug%3D%3D 10.1111/j.1398-9995.1995.tb05051.x Pedersen B, Dahl R, Richards DH, et al. Once daily fluticasone propionate aqueous nasal spray controls symptoms of most patients with seasonal allergic rhinitis. Allergy 1995 Oct; 50: 794–9
56. 56. ZM Munk D Pearlman D Graft 1994 Intranasal fluticasone propionate is effective and well-tolerated in adolescents with seasonal allergic rhinitis Pediatr Asthma Allergy Immunol 8 1 39 46 10.1089/pai.1994.8.39 Munk ZM, Pearlman D, Graft D, et al. Intranasal fluticasone propionate is effective and well-tolerated in adolescents with seasonal allergic rhinitis. Pediatr Asthma Allergy Immunol 1994; 8(1): 39–46
57. 57. A Boner L Sette L Martinati 1995 The efficacy and tolerability of fluticasone propionate aqueous nasal spray in children with seasonal allergic rhinitis Allergy 50 498 505 7573843 1:STN:280:DyaK28%2FktVKmsA%3D%3D 10.1111/j.1398-9995.1995.tb01185.x Boner A, Sette L, Martinati L, et al. The efficacy and tolerability of fluticasone propionate aqueous nasal spray in children with seasonal allergic rhinitis. Allergy 1995 Jun; 50: 498–505
58. 58. SP Galant RC Ahrens RJ Dockhorn 1994 Treatment of seasonal allergic rhinitis with once-daily intranasal fluticasone propionate therapy in children J Pediatr 125 628 34 10.1016/S0022-3476(94)70025-7 Galant SP, Ahrens RC, Dockhorn RJ, et al. Treatment of seasonal allergic rhinitis with once-daily intranasal fluticasone propionate therapy in children. J Pediatr 1994 Oct; 125: 628–34
59. 59. J Grossman C Banov EA Bronsky 1993 Fluticasone propionate aqueous nasal spray is safe and effective for children with seasonal allergic rhinitis Pediatrics 92 594 9 8414833 1:STN:280:DyaK2c%2FitFWqtA%3D%3D Grossman J, Banov C, Bronsky EA, et al. Fluticasone propionate aqueous nasal spray is safe and effective for children with seasonal allergic rhinitis. Pediatrics 1993 Oct; 92: 594–9
60. 60. V Lund I Stokes B Davies 1990 A placebo-controlled study of fluticasone propionate and beclomethasone dipropionate in seasonal rhinitis Clin Exp Allergy 20 102 Lund V, Stokes I, Davies B, et al. A placebo-controlled study of fluticasone propionate and beclomethasone dipropionate in seasonal rhinitis. Clin Exp Allergy 1990; 20 Suppl. 1: 102
61. 61. H Malmberg E Holopainen 1990 Fluticasone propionate once daily in patients with seasonal rhinitis: a European multi-centre study Clin Exp Allergy 29 102 Malmberg H, Holopainen E. Fluticasone propionate once daily in patients with seasonal rhinitis: a European multi-centre study. Clin Exp Allergy 1990; 29 Suppl. 1: 102
62. 62. PH Ratner BR Pauli SR Findlay 1992 Fluticasone propionate given once daily is as effective for seasonal allergic rhinitis as beclomethasone dipropionate given twice daily J Allergy Clin Immunol 90 285 91 1527313 1:STN:280:DyaK38vgslaisw%3D%3D 10.1016/S0091-6749(05)80005-3 Ratner PH, Pauli BR, Findlay SR, et al. Fluticasone propionate given once daily is as effective for seasonal allergic rhinitis as beclomethasone dipropionate given twice daily. J Allergy Clin Immunol 1992 Sep; 90: 285–91
63. 63. MA Stern P Harris R Dahl 1994 A placebo controlled study comparing budesonide 256µg and 128µg with fluticasone propionate 200µg in patients with seasonal allergic rhinitis [abstract] Eur Respir J 7 18 31s Stern MA, Harris P, Dahl R, et al. A placebo controlled study comparing budesonide 256µg and 128µg with fluticasone propionate 200µg in patients with seasonal allergic rhinitis [abstract]. Eur Respir J 1994; 7 Suppl. 18: 31s
64. 64. TA Johannessen 1990 A comparison of fluticasone propionate, flunisolide and placebo in patients with seasonal allergic rhinitis to birch pollen — a multicentre trial Clin Exp Allergy 20 102 Johannessen TA. A comparison of fluticasone propionate, flunisolide and placebo in patients with seasonal allergic rhinitis to birch pollen — a multicentre trial. Clin Exp Allergy 1990; 20 Suppl. 1: 102
65. 65. P Small PA Houle J Day 1996 Triamcinolone acetonide nasal spray (T) vs fluticasone propionate aqueous nasal spray (F) in patients with seasonal allergic rhinitis [abstract] J Allergy Clin Immunol 97 433 10.1016/S0091-6749(96)81221-8 Small P, Houle PA, Day J, et al. Triamcinolone acetonide nasal spray (T) vs fluticasone propionate aqueous nasal spray (F) in patients with seasonal allergic rhinitis [abstract]. J Allergy Clin Immunol 1996 Jan; 97 (Pt3): 433
66. 66. U Belling 1990 Once daily treatment with fluticasone propionate aqueous nasal spray or astemizole tablets for seasonal rhinitis [abstract] Clin Exp Allergy 20 98 Belling U. Once daily treatment with fluticasone propionate aqueous nasal spray or astemizole tablets for seasonal rhinitis [abstract]. Clin Exp Allergy 1990; 20 Suppl. 1: 98
67. 67. R Lemanske K Dunn S Galant 1994 Fluticasone propionate aqueous nasal spray is more effective than astemizole in the treatment of seasonal allergic rhinitis [abstract] J Allergy Clin Immunol 93 165 Lemanske R, Dunn K, Galant S, et al. Fluticasone propionate aqueous nasal spray is more effective than astemizole in the treatment of seasonal allergic rhinitis [abstract]. J Allergy Clin Immunol 1994 Jan; 93 (Pt2): 165
68. 68. WE Stricker JT Klimas L Mendelson 1994 Intranasal fluticasone propionate is more effective than astemizole for seasonal allergic rhinitis [abstract] Ann Allergy 72 86 Stricker WE, Klimas JT, Mendelson L, et al. Intranasal fluticasone propionate is more effective than astemizole for seasonal allergic rhinitis [abstract]. Ann Allergy 1994 Jan; 72: 86
69. 69. D Vervloet J-L Desfougères D Charpin 1992 Fluticasone propionate aqueous nasal spray versus cetirizine in seasonal rhinitis [abstract] J Allergy Clin Immunol 89 304 Vervloet D, Desfougères J-L, Charpin D. Fluticasone propionate aqueous nasal spray versus cetirizine in seasonal rhinitis [abstract]. J Allergy Clin Immunol 1992 Jan; 89: 304
70. 70. C Cook M Wisniewski F Cox 1996 Intranasal fluticasone propionate (FP) is more effective than loratadine (LOR) for the treatment of seasonal allergic rhinitis [abstract] Allergy 51 31 152 Cook C, Wisniewski M, Cox F, et al. Intranasal fluticasone propionate (FP) is more effective than loratadine (LOR) for the treatment of seasonal allergic rhinitis [abstract]. Allergy 1996; 51 Suppl. 31: 152
71. 71. P Géhanno JL Desfourgères 1993 Fluticasone propionate aqueous nasal spray once daily versus loratadine once daily in the treatment of seasonal allergic rhinitis [abstract] Eur Respir J 6 17 603s Géhanno P, Desfourgères JL. Fluticasone propionate aqueous nasal spray once daily versus loratadine once daily in the treatment of seasonal allergic rhinitis [abstract]. Eur Respir J 1993; 6 (Suppl. 17): 603s
72. 72. AS Nayak D Shulan DI Bernstein 1996 Intranasal fluticasone propionate is more effective than loratadine for treatment of seasonal allergic rhinitis symptoms [abstract] J Allergy Clin Immunol 97 198 10.1016/S0091-6749(96)80281-8 Nayak AS, Shulan D, Bernstein DI, et al. Intranasal fluticasone propionate is more effective than loratadine for treatment of seasonal allergic rhinitis symptoms [abstract]. J Allergy Clin Immunol 1996 Jan; 97 (Pt3): 198
73. 73. EH Ramsdale PA Kline 1991 Comparison of once daily treatment with an antihistamine (loratadine) and topical steroid (fluticasone propionate) during the ragweed pollen season J Allergy and Clinical Immunology 87 298 10.1016/0091-6749(91)91918-J Ramsdale EH, Kline PA. Comparison of once daily treatment with an antihistamine (loratadine) and topical steroid (fluticasone propionate) during the ragweed pollen season. J Allergy and Clinical Immunology 1991; 87: 298
74. 74. D Shulan KD Reed G Anschuetz 1996 Intranasal fluticasone propionate (Fp) compared with loratadine (LOR) in the 1995 spring tree season [abstract] Ann Allergy Asthma Immunol 76 96 Shulan D, Reed KD, Anschuetz G, et al. Intranasal fluticasone propionate (Fp) compared with loratadine (LOR) in the 1995 spring tree season [abstract]. Ann Allergy Asthma Immunol 1996 Jan; 76: 96
75. 75. R Darnell A Pecoud DH Richards 1994 A double-blind comparison of fluticasone propionate aqueous nasal spray, terfenadine tablets and placebo in the treatment of patients with seasonal allergic rhinitis to grass pollen Clin Exp Allergy 24 1144 50 7889428 1:STN:280:DyaK2M7ps1WitQ%3D%3D Darnell R, Pecoud A, Richards DH. A double-blind comparison of fluticasone propionate aqueous nasal spray, terfenadine tablets and placebo in the treatment of patients with seasonal allergic rhinitis to grass pollen. Clin Exp Allergy 1994 Dec; 24: 1144–50
76. 76. EF Juniper GH Guyatt J Dolovich 1994 Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials J Allergy Clin Immunol 93 413 23 8120268 1:STN:280:DyaK2c7msFegtw%3D%3D 10.1016/0091-6749(94)90349-2 Juniper EF, Guyatt GH, Dolovich J. Assessment of quality of life in adolescents with allergic rhinoconjunctivitis: development and testing of a questionnaire for clinical trials. J Allergy Clin Immunol 1994 Feb; 93: 413–23
77. 77. MA Stern C Benincasa 1993 Once daily fluticasone propionate aqueous nasal spray prophylaxis for seasonal allergic rhinitis: is time of dosing important? [abstract] Allergy 48 16 86 Stern MA, Benincasa C. Once daily fluticasone propionate aqueous nasal spray prophylaxis for seasonal allergic rhinitis: is time of dosing important? [abstract]. Allergy 1993; 48 Suppl. 16: 86
78. 78. J Bousquet I Chanal MC Alquié 1993 Prevention of pollen rhinitis symptoms: comparison of fluticasone propionate aqueous nasal spray and disodium cromoglycate aqueous nasal spray. A multicenter, double-blind, double-dummy, parallel-group study Allergy 48 327 33 8368459 1:STN:280:DyaK3sznsl2rtg%3D%3D 10.1111/j.1398-9995.1993.tb02401.x Bousquet J, Chanal I, Alquié MC, et al. Prevention of pollen rhinitis symptoms: comparison of fluticasone propionate aqueous nasal spray and disodium cromoglycate aqueous nasal spray. A multicenter, double-blind, double-dummy, parallel-group study. Allergy 1993 Jul; 48: 327–33
79. 79. C Benincasa RS Lloyd 1994 Evaluation of fluticasone propionate aqueous nasal spray taken alone and in combination with cetirizine in the prophylactic treatment of seasonal allergic rhinitis Drug Invest 8 225 33 10.1007/BF03258482 Benincasa C, Lloyd RS. Evaluation of fluticasone propionate aqueous nasal spray taken alone and in combination with cetirizine in the prophylactic treatment of seasonal allergic rhinitis. Drug Invest 1994 Oct; 8: 225–33
80. 80. J Hebert M Drouin WH Yang 1995 Once-a-day intranasal fluticasone propionate is effective for patients with perennial allergic rhinitis [abstract] J Allergy Clin Immunol 95 197 Hebert J, Drouin M, Yang WH, et al. Once-a-day intranasal fluticasone propionate is effective for patients with perennial allergic rhinitis [abstract]. J Allergy Clin Immunol 1995 Jan; 95: 197,Pt2
81. 81. R Haye EG Gomez 1993 A multicentre study to assess long-term use of fluticasone propionate aqueous nasal spray in comparison with beclomethasone dipropionate aqueous nasal spray in the treatment of perennial rhinitis Rhinology 31 169 74 8140383 1:STN:280:DyaK2c7ovVKktw%3D%3D Haye R, Gomez EG. A multicentre study to assess long-term use of fluticasone propionate aqueous nasal spray in comparison with beclomethasone dipropionate aqueous nasal spray in the treatment of perennial rhinitis. Rhinology 1993 Dec; 31: 169–74
82. 82. M Andersson R Berglund L Greiff 1995 A comparison of budesonide nasal dry powder with fluticasone propionate aqueous nasal spray in patients with perennial allergic rhinitis Rhinology 33 18 21 7784789 1:STN:280:DyaK2MzgsValsA%3D%3D Andersson M, Berglund R, Greiff L, et al. A comparison of budesonide nasal dry powder with fluticasone propionate aqueous nasal spray in patients with perennial allergic rhinitis. Rhinology 1995 Mar; 33: 18–21
83. 83. DH Richards CM Milton 1996 Fluticasone propionate aqueous nasal spray: a well-tolerated and effective treatment for children with perennial rhinitis Pediatr Allergy Immunol 7 35 43 8792382 1:STN:280:DyaK28zosVCqtg%3D%3D 10.1111/j.1399-3038.1996.tb00103.x Richards DH, Milton CM. Fluticasone propionate aqueous nasal spray: a well-tolerated and effective treatment for children with perennial rhinitis. Pediatr Allergy Immunol 1996 Feb; 7: 35–43
84. 84. GK Scadding VJ Lund LA Jacques 1995 A placebo-controlled study of fluticasone propionate aqueous nasal spray and beclomethasone dipropionate in perennial rhinitis: efficacy in allergic and non-allergic perennial rhinitis Clin Exp Allergy 25 737 43 7584685 1:STN:280:DyaK28%2FkvVWhtg%3D%3D 10.1111/j.1365-2222.1995.tb00011.x Scadding GK, Lund VJ, Jacques LA. A placebo-controlled study of fluticasone propionate aqueous nasal spray and beclomethasone dipropionate in perennial rhinitis: efficacy in allergic and non-allergic perennial rhinitis. Clin Exp Allergy 1995 Aug; 25: 737–43
85. 85. J Seiner C Banov H Boltansky 1994 Fluticasone propionate aqueous nasal spray effectively treats perennial non-allergic rhinitis [abstract] J Allergy Clin Immunol 93 165 Seiner J, Banov C, Boltansky H, et al. Fluticasone propionate aqueous nasal spray effectively treats perennial non-allergic rhinitis [abstract]. J Allergy Clin Immunol 1994 Jan; 93 (Pt 2): 165
86. 86. GK Scadding VJ Lund M Holmstrom 1991 Clinical and physiological effects of fluticasone propionate aqueous nasal spray in the treatment of perennial rhinitis Rhinol 11 37 43 1:STN:280:DyaK3MzmtlSjtg%3D%3D Scadding GK, Lund VJ, Holmstrom M, et al. Clinical and physiological effects of fluticasone propionate aqueous nasal spray in the treatment of perennial rhinitis. Rhinol 1991; 11 Suppl.: 37–43
87. 87. J Ngamphaiboon A Thepchatri P Chatchatee 1995 A double-blind comparison of fluticasone propionate aqueous nasal spray in the treatment of perennial rhinitis in children [abstract] Allergy 50 26 67 Ngamphaiboon J, Thepchatri A, Chatchatee P. A double-blind comparison of fluticasone propionate aqueous nasal spray in the treatment of perennial rhinitis in children [abstract]. Allergy 1995; 50 Suppl. 26: 67
88. 88. S Baba T Matsunaga H Saito 1992 Clinical studies of fluticasone propionate aerosol (5th report). Study on paediatric nasal allergy [in Japanese] Jibi to Rinsho 38 367 83 Baba S, Matsunaga T, Saito H, et al. Clinical studies of fluticasone propionate aerosol (5th report). Study on paediatric nasal allergy [in Japanese]. Jibi to Rinsho 1992; 38 Suppl. 1: 367–83
89. 89. K Holmberg G Karlsson 1994 Nasal polyps: Surgery or pharmacological intervention? Eur Respir Rev 4 20 260 5 Holmberg K, Karlsson G. Nasal polyps: Surgery or pharmacological intervention? Eur Respir Rev 1994; 4(20): 260–5
90. 90. S Juliusson K Holmberg B Balder 1996 Fluticasone aqueous nasal spray in the treatment of nasal polyposis [abstract] J Allergy Clin Immunol 97 191 10.1016/S0091-6749(96)80254-5 Juliusson S, Holmberg K, Balder B, et al. Fluticasone aqueous nasal spray in the treatment of nasal polyposis [abstract]. J Allergy Clin Immunol 1996 Jan; 97 (Pt3): 191
91. 91. Lund VJ, Dorman J, Sykes AP, et al. Acoustic rhinometry in the assessment of intranasal steroid therapy for nasal polyposis [abstract]. EAACI; 1996 Jun 2–5; Budapest, Hungary
92. 92. BE Mostafa 1996 Fluticasone propionate is associated with severe infection after endoscopic polypectomy Arch Otolaryngol Head Neck Surg 122 729 31 8663944 1:STN:280:DyaK283otVSluw%3D%3D 10.1001/archotol.1996.01890190025007 Mostafa BE. Fluticasone propionate is associated with severe infection after endoscopic polypectomy. Arch Otolaryngol Head Neck Surg 1996; 122: 729–31
93. 93. JM Rowe-Jones IS Mackay 1997 Infection following functional endoscopic sinus surgery with post-operative topical nasal steroids J Allergy Clin Immunol 99 S4 Rowe-Jones JM, Mackay IS. Infection following functional endoscopic sinus surgery with post-operative topical nasal steroids. J Allergy Clin Immunol 1997; 99: S4
94. 94. J Melamed B Stone W Beaucher 1996 Anaphylaxis and flushing after the administration of intranasal fluticasone propionate [abstract] J Allergy Clin Immunol 97 350 10.1016/S0091-6749(96)80888-8 Melamed J, Stone B, Beaucher W. Anaphylaxis and flushing after the administration of intranasal fluticasone propionate [abstract]. J Allergy Clin Immunol 1996 Jan; 97 (Pt 3): 350
95. 95. R Quintiliani 1996 Hypersensitivity and adverse reactions associated with the use of newer intranasal corticosteroids for allergic rhinitis Curr Ther Res 57 478 88 1:CAS:528:DyaK28XltFSqtro%3D 10.1016/S0011-393X(96)80057-9 Quintiliani R. Hypersensitivity and adverse reactions associated with the use of newer intranasal corticosteroids for allergic rhinitis. Curr Ther Res 1996; 57: 478–88
96. 96. AF Holm T Godthelp TM Vroom 1996 Safety and efficacy of one-year treatment with fluticasone propionate on clinical signs and inflammatory cells in the nasal mucosa of allergic perennial rhinitis patients Allergologie 19 43 Holm AF, Godthelp T, Vroom TM, et al. Safety and efficacy of one-year treatment with fluticasone propionate on clinical signs and inflammatory cells in the nasal mucosa of allergic perennial rhinitis patients. Allergologie 1996; 19: 43
97. 97. J Li K Lyles C Halstenson 1994 Long-term safety study of fluticasone propionate aqueous nasal spray [abstract] In: 1994 Annual Meeting American College of Allergy and Immunology 9 9 1:CAS:528:DyaK2MXnsFOqtQ%3D%3D Li J, Lyles K, Halstenson C, et al. Long-term safety study of fluticasone propionate aqueous nasal spray [abstract]. In: 1994 Annual Meeting American College of Allergy and Immunology. 1994 Nov 5-9: 9
98. 98. CM Kozma MK Sadik ML Watrous 1996 Economic outcomes for the treatment of allergic rhinitis PharmacoEconomics 10 4 13 10172730 1:STN:280:DyaK28zmvVCjug%3D%3D 10.2165/00019053-199610010-00002 Kozma CM, Sadik MK, Watrous ML. Economic outcomes for the treatment of allergic rhinitis. PharmacoEconomics 1996 Jul; 10: 4–13
99. 99. J Bousquet M Bullinger C Fayol 1994 Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire J Allergy Clin Immunol 94 182 8 8064070 1:STN:280:DyaK2czkt1Kmtw%3D%3D 10.1053/ai.1994.v94.a54939 Bousquet J, Bullinger M, Fayol C, et al. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. J Allergy Clin Immunol 1994 Aug; 94: 182–8
100. 100. US Department of Health and Human Services NIH. Report of the NIAID task force on immunology and allergy. National Institutes of Health (NIH) 1990; 91–2414, Betheseda (MD)
101. 101. DM Fleming DL Crombie 1987 Prevalence of asthma and hay fever in England and Wales BMJ 294 279 83 3101841 1:STN:280:DyaL2s7ivFGmtg%3D%3D 10.1136/bmj.294.6567.279 Fleming DM, Crombie DL. Prevalence of asthma and hay fever in England and Wales. BMJ 1987; 294: 279–83
102. 102. P McMenamin 1994 Costs of hayfever in the United States in 1990 Ann Allergy 73 35 9 8030800 1:STN:280:DyaK2czgtlynuw%3D%3D McMenamin P. Costs of hayfever in the United States in 1990. Ann Allergy 1994; 73: 35–9
103. 103. C Berka W Chin 1994 Fluticasone propionate intranasal steroid: cost-effectiveness vs. antihistamines [abstract] J Allergy Clin Immunol 93 165 Berka C, Chin W. Fluticasone propionate intranasal steroid: cost-effectiveness vs. antihistamines [abstract]. J Allergy Clin Immunol 1994 Jan; 93: 165
104. 104. CM Kozma RM Schulz DA Sclar 1996 A comparison of costs and efficacy of intranasal fluticasone propionate and terfenadine tablets for seasonal allergic rhinitis Clin Ther 18 334 46 8733993 1:STN:280:DyaK28zivVKmsQ%3D%3D 10.1016/S0149-2918(96)80014-2 Kozma CM, Schulz RM, Sclar DA. A comparison of costs and efficacy of intranasal fluticasone propionate and terfenadine tablets for seasonal allergic rhinitis. Clin Ther 1996 Mar–Apr; 18: 334–46
105. 105. JI Mackowiak 1994 Fluticasone propionate aqueous nasal spray (FP) improves rhinitis quality of life and reduces lost labor costs [abstract] Ann Allergy 72 99 Mackowiak JI. Fluticasone propionate aqueous nasal spray (FP) improves rhinitis quality of life and reduces lost labor costs [abstract]. Ann Allergy 1994 Jan; 72: 99
106. 106. JE Adams NJM Blackman DB Tesarowski 1996 Pharmacoeconomic benefits of fluticasone propionate aqueous nasal spray 200µ once daily in perennial allergic rhinitis [abstract] J Allergy Clin Immunol 97 197 10.1016/S0091-6749(96)80277-6 Adams JE, Blackman NJM, Tesarowski DB, et al. Pharmacoeconomic benefits of fluticasone propionate aqueous nasal spray 200µ once daily in perennial allergic rhinitis [abstract]. J Allergy Clin Immunol 1996 Jan; 97: 197
107. 107. HF Krause 1995 Pharmacotherapy of perennial and seasonal allergic rhinitis Clin Immunother 3 4 308 24 10.1007/BF03259282 Krause HF. Pharmacotherapy of perennial and seasonal allergic rhinitis. Clin Immunother 1995; 3(4): 308–24
108. 108. F Horak 1993 Seasonal allergic rhinitis. Newer treatment approaches Drugs 45 518 27 7684672 1:STN:280:DyaK3s3nt1Kqsw%3D%3D 10.2165/00003495-199345040-00004 Horak F. Seasonal allergic rhinitis. Newer treatment approaches. Drugs 1993 Apr; 45: 518–27
109. 109. VJ Lund 1995 Practical application of the international consensus on the management of rhinitis Clin Immunother 4 4 270 8 10.1007/BF03259292 Lund VJ. Practical application of the international consensus on the management of rhinitis. Clin Immunother 1995; 4(4): 270–8
110. 110. HF Krause 1992 Antihistamines and decongestants Otolaryngol Head Neck Surg 107 835 40 1281916 1:STN:280:DyaK3s7gvFOhsQ%3D%3D Krause HF. Antihistamines and decongestants. Otolaryngol Head Neck Surg 1992; 107: 835–40
111. 111. WW Busse 1994 Role of antihistamines in allergic disease Ann Allergy 71 371 5 Busse WW. Role of antihistamines in allergic disease. Ann Allergy 1994; 71: 371–5
112. 112. EO Meltzer RJ Tyrell Jr D Rich 1995 A pharmacologie continuum in the treatment of rhinorrhea: the clinician as economist J Allergy Clin Immunol 95 5 1147 52 7538521 1:STN:280:DyaK2M3ntVylsw%3D%3D 10.1016/S0091-6749(95)70220-2 Meltzer EO, Tyrell RJ Jr, Rich D, et al. A pharmacologie continuum in the treatment of rhinorrhea: the clinician as economist. J Allergy Clin Immunol 1995; 95(5) II: 1147–52
113. 113. JM Bernstein J Lee K Conboy 1985 Further observations of the role of IgE mediated hypersensitivity in recurrent otitis media with effusion Head Neck Surg 93 611 5 1:STN:280:DyaL28%2FktFCisQ%3D%3D Bernstein JM, Lee J, Conboy K, et al. Further observations of the role of IgE mediated hypersensitivity in recurrent otitis media with effusion. Head Neck Surg 1985; 93: 611–5
114. 114. GK Scadding 1995 The pathogenesis of otitis media with effusion, allergy revisited J Audiolog Med 4 173 81 Scadding GK. The pathogenesis of otitis media with effusion, allergy revisited. J Audiolog Med 1995; 4: 173–81